The global near-infrared (NIR) imaging market has experienced huge growth as government initiatives along with funding have fueled the growth of the NIR imaging market. In 2023, many governments have invested in research and development (R&D) in healthcare innovation, especially in medical imaging. In 2023, the U.S. National Institutes of Health (NIH) allocated about $5.5 billion to cancer research, most of which was directed towards early-stage detection technologies such as near-infrared imaging (NIR). The Horizon Europe program has allocated €2.2 billion for health-related R&D in Europe, a substantial portion of which focuses on NIR imaging technologies.